Bassil, C. F., Dillon, K., Anderson, G. R., Mayro, B., Askin, K. N., Winter, P. S., Harry, S., Gruber, S., Hall, T. M., Hoj, J. P., Cerda-Smith, C., Hutchinson, H. M., Killarney, S. T., Heffernan, A., Teddy, C., Singleton, K. R., Qin, L., Jubien-Girard, K., Favreau, C., Robert, G., Tivon, B., Livnah, E., London, N., Benhida, R., Auberger, P., Pendergast, A. M., Bar-Peled, L., Lonard, D. M., Martin, A. R., Puissant, A., Wood, K. C. (2026). EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge. Nature Communications. https://doi.org/10.1038/s41467-026-68424-1